\-\ Texto\\:\\ \ \(0\)\
\-\ afebrile\ \(65\)\
\-\ heart\\ rate\\ 96\ \(0\)\
\-\ bp\\ 131\\/90\ \(0\)\
\-\ spo2\\ 98\\%\ \(0\)\
\-\ physical\\ exam\\ significant\\ for\\ rales\\ bilaterally\\ in\\ the\\ lungs\\.\ \(0\)\
\-\ while\\ in\\ the\\ hospital\\,\\ the\\ patient\\ was\\ treated\\ with\\ a\\ gentle\\ diuresis\\.\\ \\ medications\\ including\\ an\\ ace\\-inhibitor\\ and\\ beta\\ blocker\\ were\\ initiated\\ during\\ hospitalization\\ and\\ were\\ to\\ be\\ continued\\ at\\ discharge\\.\\ \\ obstretrics\\ and\\ gynecology\\ advised\\ long\\-term\\ contraception\\ and\\ counseled\\ patient\\ as\\ to\\ the\\ need\\ of\\ avoiding\\ future\\ pregnancy\\ which\\ could\\ be\\ life\\-threatening\\.\\ \\ the\\ patient\\ was\\ to\\ follow\\-up\\ with\\ her\\ primary\\ care\\ physician\\ and\\ pulmonologist\\ in\\ 4\\ weeks\\.\ \(0\)\
\-\ chest\\ radiograph\\ demonstrates\\ cardiac\\ enlargement\\ and\\ vascular\\ prominence\\ and\\ opacity\\ of\\ the\\ right\\ lower\\ lung\\.\\ \\ \ \(0\)\
\-\ ct\\ demonstrates\\ cardiac\\ enlargement\\ with\\ dilated\\ left\\ ventricle\\ and\\ small\\ bilateral\\ pleural\\ effusions\\ as\\ well\\ as\\ patchy\\ areas\\ of\\ airspace\\ consolidation\\ bilaterally\\,\\ compatible\\ with\\ diffuse\\ alveolar\\ hemorrhage\\.\\ \ \(0\)\
\-\ tte\\ shows\\ severe\\ apical\\ and\\ periapical\\ hypokinesia\\ with\\ an\\ ef\\ of\\ only\\ 10\\-15\\%\\.\ \(0\)\
\-\ peripartum\\ cardiomyopathy\ \(3\)\
\-\ \\â\\€\\¢peripartum\\ cardiomyopathy\\,\\ with\\ diffuse\\ alveolar\\ hemorrhage\\ due\\ to\\ acute\\ onset\\ severe\\ lv\\ dysfunction\ \(0\)\
\-\ \\â\\€\\¢cardiomyopathy\\ of\\ other\\ cause\\,\\ with\\ patchy\\ consolidation\\ due\\ to\\ pneumonia\\ or\\ hemorrhage\\ associated\\ with\\ immune\\ disorder\ \(0\)\
\-\ 22\\ year\\ old\\ g1p1\\ presents\\ with\\ hemoptysis\\ and\\ shortness\\ of\\ breath\\ for\\ 1\\ day\\.\\ \\ she\\ is\\ 8\\ days\\ post\\ induced\\ labor\\ and\\ delivery\\ at\\ 36\\ weeks\\ due\\ to\\ pre\\-eclampsia\\ and\\ was\\ discharged\\ 2\\ days\\ ago\\ on\\ beta\\ blocker\\ and\\ clonidine\\ patch\\.\ \(0\)\
\-\ this\\ patient\\ demonstrated\\ new\\ onset\\ of\\ cardiac\\ enlargement\\ with\\ left\\ ventricular\\ dilatation\\ and\\ severely\\ reduced\\ ejection\\ fraction\\ to\\ 10\\-15\\%\\ approximately\\ 1\\ week\\ after\\ labor\\ and\\ delivery\\.\\ \\ given\\ no\\ other\\ predisposing\\ factors\\ for\\ cardiomyopathy\\ and\\ timing\\ of\\ onset\\,\\ the\\ patient\\ was\\ diagnosed\\ with\\ peripartum\\ cardiomyopathy\\.\\ \\ this\\ patient\\ suffered\\ from\\ pre\\-eclampia\\ during\\ and\\ after\\ her\\ pregnancy\\,\\ which\\ is\\ has\\ been\\ reported\\ as\\ a\\ risk\\ factor\\ for\\ peripartum\\ cardiomyopathy\\.\\ \\ imaging\\ demonstrated\\ evidence\\ of\\ diffuse\\ alveolar\\ hemorrhage\\ which\\ was\\ determined\\ to\\ be\\ due\\ to\\ rapid\\ onset\\ of\\ pulmonary\\ venous\\ hypertension\\ associated\\ with\\ the\\ acute\\ development\\ of\\ severe\\ left\\ ventricular\\ dysfunction\\ as\\ immune\\ workup\\ and\\ bronchoscopy\\ were\\ negative\\ for\\ another\\ cause\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cardiomyopathy\\:\\ 0\\.3792052472881919\ \(0\)\
\-\ peripartum\\:\\ 0\\.3207144239957273\ \(0\)\
\-\ and\\:\\ 0\\.195154307516371\ \(0\)\
\-\ alveolar\\:\\ 0\\.16520420433395855\ \(0\)\
\-\ blocker\\:\\ 0\\.15506506946415044\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.1405150385579843\ \(0\)\
\-\ onset\\:\\ 0\\.13476522428830318\ \(0\)\
\-\ labor\\:\\ 0\\.12739635901014565\ \(0\)\
\-\ with\\:\\ 0\\.12328709508431934\ \(0\)\
\-\ enlargement\\:\\ 0\\.12067413925931181\ \(0\)\
\-\ due\\:\\ 0\\.12063876014092188\ \(0\)\
\-\ to\\:\\ 0\\.1180524659071931\ \(0\)\
\-\ cardiac\\:\\ 0\\.116885189462491\ \(0\)\
\-\ immune\\:\\ 0\\.11681207394271925\ \(0\)\
\-\ of\\:\\ 0\\.11294568547380228\ \(0\)\
\-\ beta\\:\\ 0\\.10897390963807968\ \(0\)\
\-\ as\\:\\ 0\\.1053916398206124\ \(0\)\
\-\ patient\\:\\ 0\\.10239157995596435\ \(0\)\
\-\ patchy\\:\\ 0\\.10215165013832227\ \(0\)\
\-\ dysfunction\\:\\ 0\\.10189436199585822\ \(0\)\
\-\ severe\\:\\ 0\\.09964387266131335\ \(0\)\
\-\ diffuse\\:\\ 0\\.0987121198712165\ \(0\)\
\-\ delivery\\:\\ 0\\.09862577418472109\ \(0\)\
\-\ consolidation\\:\\ 0\\.09698951381575541\ \(0\)\
\-\ was\\:\\ 0\\.09142839202221818\ \(0\)\
\-\ ventricular\\:\\ 0\\.08827017845320173\ \(0\)\
\-\ pregnancy\\:\\ 0\\.08587477567757736\ \(0\)\
\-\ obstretrics\\:\\ 0\\.08390803398564708\ \(0\)\
\-\ the\\:\\ 0\\.08375441644180494\ \(0\)\
\-\ were\\:\\ 0\\.08113748422108008\ \(0\)\
\-\ contraception\\:\\ 0\\.08017860599893183\ \(0\)\
\-\ clonidine\\:\\ 0\\.08017860599893183\ \(0\)\
\-\ for\\:\\ 0\\.07951350564613355\ \(0\)\
\-\ gentle\\:\\ 0\\.07380310674535996\ \(0\)\
\-\ diuresis\\:\\ 0\\.07380310674535996\ \(0\)\
\-\ hypokinesia\\:\\ 0\\.07380310674535996\ \(0\)\
\-\ ef\\:\\ 0\\.0723852440291294\ \(0\)\
\-\ which\\:\\ 0\\.071573403453148\ \(0\)\
\-\ cause\\:\\ 0\\.07148751680146796\ \(0\)\
\-\ counseled\\:\\ 0\\.07115703547850336\ \(0\)\
\-\ avoiding\\:\\ 0\\.07115703547850336\ \(0\)\
\-\ periapical\\:\\ 0\\.07115703547850336\ \(0\)\
\-\ tte\\:\\ 0\\.0700736787586447\ \(0\)\
\-\ bilaterally\\:\\ 0\\.06998498388964391\ \(0\)\
\-\ g1p1\\:\\ 0\\.06910458314984518\ \(0\)\
\-\ gynecology\\:\\ 0\\.06822792953681396\ \(0\)\
\-\ pulmonologist\\:\\ 0\\.0674276074917881\ \(0\)\
\-\ during\\:\\ 0\\.06646644926712782\ \(0\)\
\-\ days\\:\\ 0\\.06642924844087555\ \(0\)\
\-\ timing\\:\\ 0\\.06600974477555753\ \(0\)\
\-\ her\\:\\ 0\\.06555827856609915\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0644910572232765\ \(0\)\
\-\ lv\\:\\ 0\\.06422391694582469\ \(0\)\
\-\ be\\:\\ 0\\.06385272295430255\ \(0\)\
\-\ predisposing\\:\\ 0\\.06369817950507282\ \(0\)\
\-\ weeks\\:\\ 0\\.06289041313322478\ \(0\)\
\-\ patch\\:\\ 0\\.06272908389627331\ \(0\)\
\-\ fraction\\:\\ 0\\.06228031678884227\ \(0\)\
\-\ spo2\\:\\ 0\\.061852430283242096\ \(0\)\
\-\ ejection\\:\\ 0\\.05996875151835757\ \(0\)\
\-\ advised\\:\\ 0\\.058406036971359626\ \(0\)\
\-\ hospitalization\\:\\ 0\\.05784841769225282\ \(0\)\
\-\ suffered\\:\\ 0\\.05784841769225282\ \(0\)\
\-\ initiated\\:\\ 0\\.057322680251500974\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.057322680251500974\ \(0\)\
\-\ 96\\:\\ 0\\.057070667195134143\ \(0\)\
\-\ acute\\:\\ 0\\.05676655327887512\ \(0\)\
\-\ airspace\\:\\ 0\\.05635358464270144\ \(0\)\
\-\ severely\\:\\ 0\\.05635358464270144\ \(0\)\
\-\ prominence\\:\\ 0\\.055476931029670225\ \(0\)\
\-\ associated\\:\\ 0\\.05530932546548374\ \(0\)\
\-\ other\\:\\ 0\\.05449513117079983\ \(0\)\
\-\ hemoptysis\\:\\ 0\\.054301132314043245\ \(0\)\
\-\ apical\\:\\ 0\\.05394038407117901\ \(0\)\
\-\ left\\:\\ 0\\.05369411634645896\ \(0\)\
\-\ demonstrates\\:\\ 0\\.05271888103102677\ \(0\)\
\-\ future\\:\\ 0\\.05262415665598617\ \(0\)\
\-\ compatible\\:\\ 0\\.05247212177045599\ \(0\)\
\-\ induced\\:\\ 0\\.05203053771778776\ \(0\)\
\-\ rales\\:\\ 0\\.051609186133355064\ \(0\)\
\-\ after\\:\\ 0\\.05090634348049977\ \(0\)\
\-\ 98\\:\\ 0\\.0508203113843386\ \(0\)\
\-\ reduced\\:\\ 0\\.0503296403267244\ \(0\)\
\-\ determined\\:\\ 0\\.049978085389129574\ \(0\)\
\-\ workup\\:\\ 0\\.049420466110022765\ \(0\)\
\-\ factor\\:\\ 0\\.04920655179062969\ \(0\)\
\-\ effusions\\:\\ 0\\.04910143177609836\ \(0\)\
\-\ rapid\\:\\ 0\\.04879309336823318\ \(0\)\
\-\ need\\:\\ 0\\.04830110973107251\ \(0\)\
\-\ discharge\\:\\ 0\\.04704897944744017\ \(0\)\
\-\ physician\\:\\ 0\\.04602153719251678\ \(0\)\
\-\ opacity\\:\\ 0\\.045655038464215904\ \(0\)\
\-\ afebrile\\:\\ 0\\.04530258533794242\ \(0\)\
\-\ discharged\\:\\ 0\\.04503003499247497\ \(0\)\
\-\ disorder\\:\\ 0\\.04438202757875271\ \(0\)\
\-\ factors\\:\\ 0\\.04438202757875271\ \(0\)\
\-\ medications\\:\\ 0\\.04401406246525042\ \(0\)\
\-\ 36\\:\\ 0\\.043431722377216174\ \(0\)\
\-\ development\\:\\ 0\\.04337546592566018\ \(0\)\
\-\ continued\\:\\ 0\\.04299102006745773\ \(0\)\
\-\ another\\:\\ 0\\.04293738783878868\ \(0\)\
\-\ dilatation\\:\\ 0\\.042831052537057816\ \(0\)\
\-\ bp\\:\\ 0\\.042570471337401335\ \(0\)\
\-\ shortness\\:\\ 0\\.04207046230826802\ \(0\)\
\-\ pneumonia\\:\\ 0\\.04141318982082726\ \(0\)\
\-\ 22\\:\\ 0\\.041323013597001995\ \(0\)\
\-\ hypertension\\:\\ 0\\.040145420344025386\ \(0\)\
\-\ an\\:\\ 0\\.0401273079038017\ \(0\)\
\-\ rate\\:\\ 0\\.03975889703778332\ \(0\)\
\-\ at\\:\\ 0\\.03963578776252966\ \(0\)\
\-\ pleural\\:\\ 0\\.03949768147824133\ \(0\)\
\-\ in\\:\\ 0\\.03915713730483098\ \(0\)\
\-\ hospital\\:\\ 0\\.03875579805881078\ \(0\)\
\-\ lungs\\:\\ 0\\.03872191993153722\ \(0\)\
\-\ ventricle\\:\\ 0\\.038621027865210114\ \(0\)\
\-\ breath\\:\\ 0\\.03845529543261188\ \(0\)\
\-\ ago\\:\\ 0\\.03838982966759058\ \(0\)\
\-\ could\\:\\ 0\\.0381643006524304\ \(0\)\
\-\ diagnosed\\:\\ 0\\.038006528325180845\ \(0\)\
\-\ reported\\:\\ 0\\.03779009713584285\ \(0\)\
\-\ dilated\\:\\ 0\\.03757864181958067\ \(0\)\
\-\ including\\:\\ 0\\.037548826878867334\ \(0\)\
\-\ care\\:\\ 0\\.03748948537525158\ \(0\)\
\-\ risk\\:\\ 0\\.03748948537525158\ \(0\)\
\-\ venous\\:\\ 0\\.03745995757732002\ \(0\)\
\-\ heart\\:\\ 0\\.03648202208205792\ \(0\)\
\-\ new\\:\\ 0\\.03629832037512382\ \(0\)\
\-\ given\\:\\ 0\\.036092772130644095\ \(0\)\
\-\ this\\:\\ 0\\.03605801952539926\ \(0\)\
\-\ areas\\:\\ 0\\.03562225199496676\ \(0\)\
\-\ week\\:\\ 0\\.035290332948733225\ \(0\)\
\-\ vascular\\:\\ 0\\.034638682895916664\ \(0\)\
\-\ radiograph\\:\\ 0\\.034173402496516354\ \(0\)\
\-\ while\\:\\ 0\\.0339091352249633\ \(0\)\
\-\ approximately\\:\\ 0\\.03347851653423793\ \(0\)\
\-\ day\\:\\ 0\\.03342132732726523\ \(0\)\
\-\ only\\:\\ 0\\.032779139283049576\ \(0\)\
\-\ treated\\:\\ 0\\.03267341511723843\ \(0\)\
\-\ negative\\:\\ 0\\.03248268837263947\ \(0\)\
\-\ primary\\:\\ 0\\.03226226728988173\ \(0\)\
\-\ pulmonary\\:\\ 0\\.031981771437874486\ \(0\)\
\-\ lung\\:\\ 0\\.031916997218371074\ \(0\)\
\-\ she\\:\\ 0\\.03123305446604956\ \(0\)\
\-\ shows\\:\\ 0\\.030794279647658098\ \(0\)\
\-\ been\\:\\ 0\\.030568552953581178\ \(0\)\
\-\ significant\\:\\ 0\\.030293968349307164\ \(0\)\
\-\ evidence\\:\\ 0\\.029781014650927726\ \(0\)\
\-\ is\\:\\ 0\\.028737532319255375\ \(0\)\
\-\ post\\:\\ 0\\.028549608498615976\ \(0\)\
\-\ physical\\:\\ 0\\.02844944887561066\ \(0\)\
\-\ bilateral\\:\\ 0\\.02819833330679456\ \(0\)\
\-\ chest\\:\\ 0\\.027695361476827052\ \(0\)\
\-\ imaging\\:\\ 0\\.02757380154245095\ \(0\)\
\-\ small\\:\\ 0\\.027064851660942833\ \(0\)\
\-\ lower\\:\\ 0\\.026811294684949\ \(0\)\
\-\ exam\\:\\ 0\\.026412505477061712\ \(0\)\
\-\ well\\:\\ 0\\.025405348922866097\ \(0\)\
\-\ presents\\:\\ 0\\.025239900415540112\ \(0\)\
\-\ has\\:\\ 0\\.023965933490111786\ \(0\)\
\-\ from\\:\\ 0\\.02083813464217653\ \(0\)\
\-\ ct\\:\\ 0\\.01997512678962696\ \(0\)\
\-\ or\\:\\ 0\\.018252743771918135\ \(0\)\
\-\ right\\:\\ 0\\.01739537088686454\ \(0\)\
\-\ no\\:\\ 0\\.01706205344944558\ \(0\)\
\-\ year\\:\\ 0\\.016169658487456405\ \(0\)\
\-\ on\\:\\ 0\\.015846289415102868\ \(0\)\
\-\ old\\:\\ 0\\.01552846941414856\ \(0\)\
